var pubdImg = new Image();
pubdImg.src = '/en_GX/gx/pharma-life-sciences/assets/growth-india-cov-a.gif';
var pubzImg = new Image();
pubzImg.src = '/en_GX/gx/pharma-life-sciences/assets/money-tree-under-recovery-b.jpg';
var pubtImg = new Image();
pubtImg.src = '/en_GX/gx/pharma-life-sciences/assets/2010-ca-biomedical-a.jpg';
var pubsImg = new Image();
pubsImg.src = '/gx/eng/about/ind/pharma/pharma2020_chal-a.jpg';
var pubmImg = new Image();
pubmImg.src = '/en_GX/gx/pharma-life-sciences/assets/ph2020_taxing_times-a.jpg';
var pubbImg = new Image();
pubbImg.src = '/gx/eng/about/ind/pharma/ph2020-sm-a.jpg';



function makeSpotlight(t,c,l,f,i){
	this.title = t;
	this.copy = c;
	this.link = l;
	this.follow = f;
	this.img = i;
	this.write = writeSpotlight;
}

function writeSpotlight(){
	var str = '';
	str += '<a href="' + this.link + '">';
	str += '<img align="left" hspace="10" border="0" src="' + this.img.src + '"' + 'alt="' + this.title + '"></a>';
	str += '<b>' + this.title + '</b>' + '&nbsp;' + '<br><br>'
	str += this.copy + '&nbsp;';
    str += 'See&nbsp;' + '<a href="' + this.link + '">' + this.follow + '</a>' + '.';
	return str;
}

var newsArray = new Array();

newsArray[0] = new makeSpotlight("<span class=strongtext><font size=3 point-size=12><b>New release</b></font></span><p></p>Global pharma looks to India: Prospects for growth","Our report highlights that India now has a growing and increasingly sophisticated pharmaceutical industry of its own. It is likely to become a competitor of global pharma in some key areas, and a potential partner in others.",'/en_GX/gx/pharma-life-sciences/publications/india-growth.jhtml',"more", pubdImg).write();//Global pharma looks to India: Prospects for growth

newsArray[1] = new makeSpotlight("Under recovery? - Life sciences venture capital funding overcomes record lows, outpaces other sectors","Companies in the Life Sciences sector, which includes the biotechnology and medical device industries, captured the largest share of overall venture capital during 2009, reflecting the relative strength of the sector during the economic downturn. This year in review summary includes where venture capital investments and funding were made, the nature of transactions that took place as well as the geographic distribution of funding for the biotechnology and medical device sectors during 2009.",'/en_GX/gx/pharma-life-sciences/publications/moneytree_under-recovery.jhtml',"more", pubzImg).write();//Under recovery? - Life sciences venture capital funding overcomes record lows, outpaces other sectors

newsArray[2] = new makeSpotlight("California Biomedical Industry - 2010 Report","The 2010 report on California&#39;s biomedical industry report is a collaborative effort between the California Healthcare Institute and PricewaterhouseCoopers. It offers a comprehensive overview of the impact of the biomedical sector on California&#39;s economy.",'/en_GX/gx/pharma-life-sciences/publications/chireport2010.jhtml',"more", pubtImg).write();//California Biomedical Industry - 2010 Report

newsArray[3] = new makeSpotlight("Pharma 2020: Taxing times ahead - Which path will you take?","This paper discusses how the political, economic, scientific and social trends currently shaping the commercial environment, together with the development of new, more collaborative business models, will exert increasing pressure on effective tax rates within the industry. It also shows how companies can adapt their tax planning to support the provision of outcomes-based healthcare and remain competitive.",'/en_GX/gx/pharma-life-sciences/pharma-2020/pharma-2020-taxing-times-ahead.jhtml',"more", pubmImg).write();//Pharma 2020: Taxing times ahead - Which path will you take?

newsArray[4] = new makeSpotlight("Pharma 2020: Challenging business models","This paper suggests that alternative business models with varying degrees of collaboration will emerge to provide a basis for the industry to operate more effectively as times change. It also evaluates the advantages and disadvantages of each alternative, their strengths and weaknesses and lists some key questions to make the transition to a new business successful.",'/extweb/industry.nsf/docid/89150A737EFCF98B802575A50032D4A8',"more", pubsImg).write();//Pharma 2020: Challenging business models



newsArray[5] = new makeSpotlight("Pharma 2020: Marketing the future - Which path will you take?","This paper discusses how the industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills.  Companies need to add value to patients, and offer a package of products and health services that the market is willing to pay a premium for.",'/Extweb/pwcpublications.nsf/docid/B1221EC9D057309F852575610076732C',"more", pubbImg).write();//Pharma 2020: Marketing the future



var nIndex = 0;
var timerID = null;
function rotateSpotlight(){
	var len = newsArray.length;
	if(nIndex >= len)
		nIndex = 0;
	document.getElementById('spotlight').innerHTML = newsArray[nIndex];
	nIndex++;
	timerID = setTimeout('rotateSpotlight()',5500);
}
function pauseSpotlight() {
	if (timerID != null) {
		clearTimeout(timerID);
		timerID = null;
	}
}

function playSpotlight() {
	if (timerID == null) {
		timerID = setTimeout('rotateSpotlight()',650);
	}
}